Advertisement
Screener

Creative Medical Technology Holdings, Inc. (CELZ) Stock-Based Compensation

2.8 / 5 stars · 68/120 Roast Me

Creative Medical Technology Holdings, Inc. Stock-Based Compensation

Creative Medical Technology Holdings, Inc. (CELZ) reported Stock-Based Compensation of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Cash Flow › Operating Activities

us-gaap:ShareBasedCompensation · last filed 2026-08-07

  • Creative Medical Technology Holdings, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $0.00.
  • Creative Medical Technology Holdings, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
  • Creative Medical Technology Holdings, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
  • Creative Medical Technology Holdings, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
  • Creative Medical Technology Holdings, Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $3.48K, a 90.49% decline from fiscal 2024.
  • Creative Medical Technology Holdings, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $36.65K, a 0.00% change from fiscal 2023.
  • Creative Medical Technology Holdings, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $36.65K, a 46.69% decline from fiscal 2022.
  • Creative Medical Technology Holdings, Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $68.75K, a 88.45% decline from fiscal 2021.
Period endShare-based Payment Arrangement, Noncash Expense 0 monthShare-based Payment Arrangement, Noncash Expense 3 monthShare-based Payment Arrangement, Noncash Expense 3 month as first filedShare-based Payment Arrangement, Noncash Expense 6 monthShare-based Payment Arrangement, Noncash Expense 9 monthShare-based Payment Arrangement, Noncash Expense 12 month
2026-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07
$0.00
10-Q · filed 2026-08-07
$0.00
derived: sum of 3 quarters · filed 2026-08-07
$0.00
derived: sum of 4 quarters · filed 2026-08-07
2026-03-31$0.00
10-Q · filed 2026-05-08
$0.00
derived: sum of 2 quarters · filed 2026-05-08
$0.00
derived: sum of 3 quarters · filed 2026-05-08
$0.00
derived: sum of 4 quarters · filed 2026-08-07
2025-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-20
$0.00
derived: sum of 2 quarters · filed 2026-03-20
$0.00
derived: sum of 3 quarters · filed 2026-08-07
$3.48K
10-K · filed 2026-03-20
2025-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
$0.00
derived: sum of 2 quarters · filed 2026-08-07
$3.48K
10-Q · filed 2025-11-07
$12.65K
derived: sum of 4 quarters · filed 2026-08-07
2025-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07
$3.48K
10-Q · filed 2026-08-07
$12.65K
derived: sum of 3 quarters · filed 2026-08-07
$21.81K
derived: sum of 4 quarters · filed 2026-08-07
2025-03-31$3.48K
10-Q · filed 2026-05-08
$12.65K
derived: sum of 2 quarters · filed 2026-05-08
$21.81K
derived: sum of 3 quarters · filed 2026-05-08
$30.97K
derived: sum of 4 quarters · filed 2026-05-08
2024-12-31$9.16K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-20
$18.32K
derived: sum of 2 quarters · filed 2026-03-20
$27.49K
derived: sum of 3 quarters · filed 2026-03-20
$36.65K
10-K · filed 2026-03-20
2024-09-30$9.16K
10-Q · filed 2025-11-07
$18.32K
derived: sum of 2 quarters · filed 2025-11-07
$27.49K
10-Q · filed 2025-11-07
$36.65K
derived: sum of 4 quarters · filed 2025-11-07
2024-06-30$9.16K
10-Q · filed 2025-08-08
$18.32K
10-Q · filed 2025-08-08
$27.49K
derived: sum of 3 quarters · filed 2025-08-08
$36.65K
derived: sum of 4 quarters · filed 2025-08-08
2024-03-31$9.16K
10-Q · filed 2025-05-09
$18.32K
derived: sum of 2 quarters · filed 2025-05-09
$27.49K
derived: sum of 3 quarters · filed 2025-05-09
$36.65K
derived: sum of 4 quarters · filed 2025-05-09
2023-12-31$9.16K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14
$18.32K
derived: sum of 2 quarters · filed 2025-03-14
$27.49K
derived: sum of 3 quarters · filed 2025-03-14
$36.65K
10-K · filed 2025-03-14
2023-09-30$9.16K
10-Q · filed 2024-11-08
$18.32K
derived: sum of 2 quarters · filed 2024-11-08
$27.49K
10-Q · filed 2024-11-08
$36.65K
derived: sum of 4 quarters · filed 2024-11-08
2023-06-30$9.16K
10-Q · filed 2024-08-09
$18.32K
10-Q · filed 2024-08-09
$27.49K
derived: sum of 3 quarters · filed 2024-08-09
$36.65K
derived: sum of 4 quarters · filed 2024-08-09
2023-03-31$9.16K
10-Q · filed 2024-05-10
$18.32K
derived: sum of 2 quarters · filed 2024-05-10
$27.49K
derived: sum of 3 quarters · filed 2024-05-10
$36.55K
derived: sum of 4 quarters · filed 2024-05-10
2022-12-31$9.16K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22
$18.32K
derived: sum of 2 quarters · filed 2024-03-22
$27.39K
derived: sum of 3 quarters · filed 2024-03-22
$68.75K
10-K · filed 2024-03-22
2022-09-30$9.16K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14
$18.22K
derived: sum of 2 quarters · filed 2023-11-14
$59.58K
10-Q · filed 2023-11-14
$59.58K
derived: sum of 4 quarters · filed 2023-11-14
2022-06-30$9.06K
10-Q · filed 2023-08-11
$50.42K
10-Q · filed 2023-08-11
$50.42K
derived: sum of 3 quarters · filed 2023-08-11
$434.03K
derived: sum of 4 quarters · filed 2023-08-11
2022-03-31$41.36K
10-Q · filed 2023-05-12
$41.36K
derived: sum of 2 quarters · filed 2023-05-12
$424.97K
derived: sum of 3 quarters · filed 2023-05-12
2021-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31
$383.61K
derived: sum of 2 quarters · filed 2023-03-31
$595.38K
10-K · filed 2023-03-31
2021-09-30$383.61K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10
$595.38K
10-Q · filed 2022-11-10
2021-06-30$211.77K
10-Q · filed 2022-08-12
2020-12-31$102.08K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17
$170.32K
10-K · filed 2021-03-17
2020-09-30$68.24K
10-Q · filed 2020-11-13
2019-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17
$0.00
derived: sum of 2 quarters · filed 2021-03-17
$0.00
derived: sum of 3 quarters · filed 2021-03-17
$0.00
10-K · filed 2021-03-17
2019-09-30$0.00
10-Q · filed 2019-11-14
$0.00
derived: sum of 2 quarters · filed 2019-11-14
$0.00
10-Q · filed 2020-11-13
$0.00
derived: sum of 4 quarters · filed 2020-04-06
2019-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13
$0.00
10-Q · filed 2019-08-13
$0.00
derived: sum of 3 quarters · filed 2020-04-06
$0.00
derived: sum of 4 quarters · filed 2020-04-06
2019-03-31$0.00
10-Q · filed 2019-08-13
$0.00
derived: sum of 2 quarters · filed 2020-04-06
$0.00
derived: sum of 3 quarters · filed 2020-04-06
$0.00
derived: sum of 4 quarters · filed 2020-04-06
2018-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-06
$0.00
derived: sum of 2 quarters · filed 2020-04-06
$0.00
derived: sum of 3 quarters · filed 2020-04-06
$1.88K
10-K · filed 2020-04-06
2018-09-30$0.00
10-Q · filed 2019-11-14
$0.00
derived: sum of 2 quarters · filed 2019-11-14
$1.88K
10-Q · filed 2019-11-14
$48.00
derived: sum of 4 quarters · filed 2019-11-14
2018-06-30$0.00
10-Q · filed 2018-08-14
$1.88K
10-Q · filed 2019-08-13
$48.00
derived: sum of 3 quarters · filed 2019-08-13
$1.74K
derived: sum of 4 quarters · filed 2019-08-13
2018-03-31$0.00
10-Q · filed 2019-08-13
$1.88K
10-Q · filed 2018-05-21
$48.00
derived: sum of 2 quarters · filed 2019-08-13
$1.74K
derived: sum of 3 quarters · filed 2019-08-13
$142.69K
derived: sum of 4 quarters · filed 2019-08-13
2017-12-31$48.00
derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01
$1.74K
derived: sum of 2 quarters · filed 2019-04-01
$142.69K
derived: sum of 3 quarters · filed 2019-04-01
$144.16K
10-K · filed 2019-04-01
2017-09-30$1.69K
10-Q · filed 2018-11-14
$142.65K
derived: sum of 2 quarters · filed 2018-11-14
$144.11K
10-Q · filed 2018-11-14
$145.94K
derived: sum of 4 quarters · filed 2018-11-14
2017-06-30$140.96K
10-Q · filed 2018-08-14
$142.42K
10-Q · filed 2018-08-14
$144.25K
derived: sum of 3 quarters · filed 2018-08-14
$144.25K
derived: sum of 4 quarters · filed 2018-08-14
2017-03-31$1.47K
10-Q · filed 2018-08-03
$3.30K
derived: sum of 2 quarters · filed 2018-08-03
$3.30K
derived: sum of 3 quarters · filed 2018-08-03
$3.30K
derived: sum of 4 quarters · filed 2018-08-03
2016-12-31$1.83K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29
$1.83K
derived: sum of 2 quarters · filed 2018-03-29
$1.83K
derived: sum of 3 quarters · filed 2018-03-29
$2.56K
10-K · filed 2018-03-29
2016-09-30$0.00
10-Q · filed 2017-11-13
$0.00
derived: sum of 2 quarters · filed 2017-11-13
$735.00
10-Q · filed 2017-11-13
2016-06-30$0.00
10-Q · filed 2017-08-14
$0.00
10-Q · filed 2017-08-14
2016-03-31$0.00
10-Q · filed 2017-05-10
2015-12-31$0.00
10-K · filed 2017-02-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
AIM ImmunoTech Inc. (AIM)United States$0.006B
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
PharmaCyte Biotech, Inc. (PMCB)United States$0.005B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
WINDTREE THERAPEUTICS INC /DE/ (WINT)United States$0.003B-0.32
VivoSim Labs, INC. (VIVS)United States$0.003B
Calidi Biotherapeutics, Inc. (CLDI)United States$0.003B
CURIS INC (CRIS)United States$0.002B-0.05
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70
Silexion Therapeutics Corp (SLXN)$0.001B